Sandip Patel
Sandip Patel

S1609 DART clinical study chair; Assistant professor of medicine, UC San Diego Cancer Center;

Assistant director, Clinical Trials Office, Moores Cancer Center; Investigator, SWOG early therapeutics and rare cancers committee

Latest Stories

ClinicalTrials & Tribulations
Cancer immunotherapy, and in particular immune checkpoint blockade, has transformed oncology with the potential for durable responses even in patients with metastatic disease. To date, regulatory approvals and clinical trials have focused on the study of these agents in relatively more common tumor types, such as melanoma, non-small cell lung cancer, bladder cancer, and kidney cancer, amongst others.